• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

暴发性巨细胞性心肌炎和心源性休克：恶性胸腺瘤的一种不常见表现。

Fulminant giant cell myocarditis and cardiogenic shock: an unusual presentation of malignant thymoma.

机构信息

Division of Cardiology, Cardiac Cath Laboratory, St. John Hospital and Medical Center, 22101 Moross Road, 2nd Floor VEP, Detroit, MI 48236, USA.

出版信息

Cardiol Res Pract. 2010;2010:185896. doi: 10.4061/2010/185896. Epub 2010 May 4.

DOI:10.4061/2010/185896
PMID:20454573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2864446/
Abstract

Malignant thymoma is rarely associated with giant cell myocarditis. We present a case study that illustrates this association and cardiogenic shock with underlying tamponade. The dramatic presentation of this scenario has not been previously described.

摘要

恶性胸腺瘤很少与巨细胞性心肌炎有关。我们提出了一个病例研究，说明了这种与潜在的心包填塞相关的心源性休克的关联。这种情况的戏剧性表现以前尚未描述过。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ce/2864446/9ec658e2d99c/CRP2010-185896.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ce/2864446/178ad2e6a3e5/CRP2010-185896.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ce/2864446/eff12a028202/CRP2010-185896.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ce/2864446/8be6953f852c/CRP2010-185896.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ce/2864446/d36d5bb7c429/CRP2010-185896.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ce/2864446/9ec658e2d99c/CRP2010-185896.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ce/2864446/178ad2e6a3e5/CRP2010-185896.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ce/2864446/eff12a028202/CRP2010-185896.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ce/2864446/8be6953f852c/CRP2010-185896.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ce/2864446/d36d5bb7c429/CRP2010-185896.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ce/2864446/9ec658e2d99c/CRP2010-185896.005.jpg

相似文献

1
Fulminant giant cell myocarditis and cardiogenic shock: an unusual presentation of malignant thymoma.暴发性巨细胞性心肌炎和心源性休克：恶性胸腺瘤的一种不常见表现。
Cardiol Res Pract. 2010;2010:185896. doi: 10.4061/2010/185896. Epub 2010 May 4.
2
Fatal giant cell myocarditis after resection of thymoma.胸腺瘤切除术后发生致命性巨细胞心肌炎。
Heart. 1996 May;75(5):531-2. doi: 10.1136/hrt.75.5.531.
3
Giant Cell Myocarditis: Not Always a Presentation of Cardiogenic Shock.巨细胞性心肌炎：并非总是以心源性休克为表现。
Case Rep Cardiol. 2015;2015:173826. doi: 10.1155/2015/173826. Epub 2015 Jul 16.
4
A survival case of invasive thymoma accompanied by acute fulminant myocarditis.侵袭性胸腺瘤伴急性暴发性心肌炎的一例存活病例。
Respirol Case Rep. 2013 Dec;1(2):36-8. doi: 10.1002/rcr2.6. Epub 2013 Sep 14.
5
Short-term use of "ECMELLA" in the context of fulminant eosinophilic myocarditis with cardiogenic shock.在暴发性嗜酸性心肌炎合并心源性休克的情况下短期使用“ECMELLA”。
BMC Cardiovasc Disord. 2020 Dec 10;20(1):519. doi: 10.1186/s12872-020-01808-3.
6
An unusual case of fulminant myocarditis closely mimicking ST-segment elevation myocardial infarction and presenting as refractory cardiogenic shock complicated by multiple life-threatening arrhythmias.一例罕见的暴发性心肌炎，酷似ST段抬高型心肌梗死，表现为难治性心源性休克，并伴有多种危及生命的心律失常。
Rev Port Cardiol. 2015 Dec;34(12):771.e1-5. doi: 10.1016/j.repc.2015.03.030. Epub 2015 Nov 27.
7
Giant Cell Polymyositis and Myocarditis in a Patient With Thymoma and Myasthenia Gravis: A Postviral Autoimmune Process?胸腺瘤合并重症肌无力患者的巨细胞性多肌炎和心肌炎：病毒后自身免疫过程？
J Neuropathol Exp Neurol. 2018 Aug 1;77(8):661-664. doi: 10.1093/jnen/nly041.
8
The Clinical Potential of Impella 5.0 Support in the Treatment of Recurrent Fulminant Viral Myocarditis with Profound Cardiogenic Shock.Impella 5.0支持治疗复发性暴发性病毒性心肌炎伴严重心源性休克的临床潜力
Intern Med. 2019 May 15;58(10):1459-1462. doi: 10.2169/internalmedicine.1866-18. Epub 2019 Jan 10.
9
Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation.经皮体外膜肺氧合支持下暴发性心肌炎所致心源性休克患者的良好临床结局。
Eur Heart J. 2005 Oct;26(20):2185-92. doi: 10.1093/eurheartj/ehi411. Epub 2005 Jul 13.
10
[Thymoma associated with myasthenia, erythroblastopenia, myositis and giant cell myocarditis. One case (author's transl)].胸腺瘤伴重症肌无力、红细胞生成减少、肌炎和巨细胞性心肌炎。1例报告（作者译）
Nouv Presse Med. 1981 Jun 6;10(25):2097-8, 2103-4.

引用本文的文献

1
Cardiac Toxicity Associated with Immune Checkpoint Inhibitors: A Systematic Review.免疫检查点抑制剂相关心脏毒性：系统评价。
Int J Mol Sci. 2022 Sep 19;23(18):10948. doi: 10.3390/ijms231810948.
2
Successful bridge to recovery in a patient with fulminant giant cell myocarditis that developed from multiple autoimmune disorders including myasthenia gravis: a case report.一名患有包括重症肌无力在内的多种自身免疫性疾病并发暴发性巨细胞心肌炎的患者成功康复：病例报告。
Eur Heart J Case Rep. 2022 Feb 3;6(2):ytac046. doi: 10.1093/ehjcr/ytac046. eCollection 2022 Feb.
3
Autoimmune disorders and paraneoplastic syndromes in thymoma.

本文引用的文献

1
Fatal giant cell myocarditis after thymoma resection in myasthenia gravis.重症肌无力患者胸腺切除术后发生致命性巨细胞性心肌炎。
J Thorac Cardiovasc Surg. 2006 Feb;131(2):494-5. doi: 10.1016/j.jtcvs.2005.09.035.
2
A case report of giant cell myocarditis and myositis observed during the clinical course of invasive thymoma associated with myasthenia gravis.1例侵袭性胸腺瘤合并重症肌无力临床过程中观察到的巨细胞性心肌炎和肌炎病例报告
Keio J Med. 2004 Mar;53(1):30-42.
3
Combined immunosuppression for the treatment of idiopathic giant cell myocarditis.
胸腺瘤中的自身免疫性疾病和副肿瘤综合征。
J Thorac Dis. 2020 Dec;12(12):7571-7590. doi: 10.21037/jtd-2019-thym-10.
4
Giant cell myocarditis causing sudden death in a patient with sarcoidosis.结节病患者中巨细胞性心肌炎导致猝死。
Autops Case Rep. 2020 Nov 20;10(4):e2020238. doi: 10.4322/acr.2020.238.
5
Outcomes of Mechanical Circulatory Support for Giant Cell Myocarditis: A Systematic Review.巨细胞性心肌炎的机械循环支持结果：一项系统评价
J Clin Med. 2020 Dec 1;9(12):3905. doi: 10.3390/jcm9123905.
6
Immune checkpoint inhibitors for treatment of thymic epithelial tumors: how to maximize benefit and optimize risk?用于治疗胸腺上皮肿瘤的免疫检查点抑制剂：如何最大化获益并优化风险？
Mediastinum. 2019 Sep;3. doi: 10.21037/med.2019.08.02. Epub 2019 Sep 9.
7
A case of cardiac tamponade shock due to bleeding from an advanced thymoma.一例因晚期胸腺瘤出血导致的心包填塞性休克。
Gen Thorac Cardiovasc Surg. 2013 Dec;61(12):723-7. doi: 10.1007/s11748-012-0186-0. Epub 2012 Nov 28.
联合免疫抑制治疗特发性巨细胞性心肌炎。
Mayo Clin Proc. 1999 Dec;74(12):1221-6. doi: 10.4065/74.12.1221.
4
A case of giant cell myocarditis and malignant thymoma: a postmortem diagnosis by needle biopsy.一例巨细胞性心肌炎合并恶性胸腺瘤：经针吸活检的尸检诊断
Clin Cardiol. 1998 Jan;21(1):48-51. doi: 10.1002/clc.4960210109.
5
Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators.特发性巨细胞性心肌炎——自然病程与治疗。多中心巨细胞性心肌炎研究组研究者
N Engl J Med. 1997 Jun 26;336(26):1860-6. doi: 10.1056/NEJM199706263362603.
6
A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction.一种通过用心肌肌球蛋白组分免疫诱导大鼠发生巨细胞性心肌炎的新型实验模型。
Clin Immunol Immunopathol. 1990 Nov;57(2):250-62. doi: 10.1016/0090-1229(90)90039-s.